You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / ABIM MOC

Conceptual Overview of Treatment Intensification in Hormone-Sensitive Prostate Cancer

  • Authors: Andrew J. Armstrong, MD, ScM, FACP
  • CME / ABIM MOC Released: 8/12/2022
  • THIS ACTIVITY HAS EXPIRED FOR CREDIT
  • Valid for credit through: 8/12/2023, 11:59 PM EST
Start Activity


Target Audience and Goal Statement

This activity is intended for oncologists, urologists, and other healthcare providers who care for patients with prostate cancer.

The goal of this activity is for learners to understand the nuances and strategies of treatment intensification in HSPC through discussions of the foundational concepts, intensification strategies in the clinic, barriers to care, and other practical integration aspects of treatment intensification for HSPC.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Impact of treatment intensification in patients with HSPC
    • Optimal candidate for treatment intensification in the setting of HSPC
    • Barriers to strategically employing treatment intensification in patients with HSPC
  • Demonstrate greater confidence in their ability to
    • Use treatment intensification strategies to improve outcomes for patients with HSPC


Disclosures

Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.

Disclosures for additional planners can be found here.


Faculty

  • Andrew J. Armstrong, MD, ScM, FACP

    Professor of Medicine, Surgery, Pharmacology, and Cancer Biology
    Director of Research
    Duke Cancer Institute Center for Prostate and Urologic Cancers
    Divisions of Medical Oncology and Urology
    Duke University
    Durham, North Carolina

    Disclosures

    Andrew J Armstrong, MD, ScM FACP, has the following relevant financial relationships: 
    Consultant or advisor for: Astellas; AstraZeneca; Bayer; Bristol Myers Squibb; Celgene; Clovis; Dendreon; Epic Sciences; Exact Sciences; Forma; Janssen; Merck; Pfizer
    Research funding from: Amgen; Astellas; AstraZeneca; Bayer; Bristol Myers Squibb; Celgene; Constellation; Dendreon; Forma; Genentech/Roche; Janssen; Merck; Pfizer 

Editor

  • Davecia R. Cameron, MS

    Medical Education Director, Medscape, LLC

    Disclosures

    Davecia R Cameron, MS, has no relevant financial relationships.

Compliance Reviewer

  • Amanda Jett, PharmD, BCACP

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Amanda Jett, PharmD, BCACP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.


Accreditation Statements

Medscape

Interprofessional Continuing Education

In support of improving patient care, Medscape LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read about the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or print it out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / ABIM MOC

Conceptual Overview of Treatment Intensification in Hormone-Sensitive Prostate Cancer

Authors: Andrew J. Armstrong, MD, ScM, FACPFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED FOR CREDIT

CME / ABIM MOC Released: 8/12/2022

Valid for credit through: 8/12/2023, 11:59 PM EST

processing....

Educational Impact Challenge

The goal of this activity is for learners to understand the nuances and strategies of treatment intensification in HSPC through discussions of the foundational concepts, intensification strategies in the clinic, barriers to care, and other practical integration aspects of treatment intensification for HSPC.

Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.

  • Print